Thursday, June 16, 2016

BRIEF-Merck's Keytruda shows superior progression-free, overall survival in lung cancer patients

… patients with advanced non-small cell
lung cancer
* Keynote-024 trial met its primary …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)